Moderna is one of the pharmaceutical companies best known for developing the messenger RNA vaccine against Covid-19.
(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...
A government advisory committee has canceled a meeting on flu shot recommendations, raising concerns amid shifts in ...
As Elon Musk, Donald Trump, and RFK Jr. offer unsettling displays at the first cabinet meeting, a former HHS official ...
Novavax's fourth-quarter loss narrowed on Thursday, helped by reduced selling and administrative expenses of COVID-19 ...
Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...
The European Union is getting good at adapting to unprecedented circumstances. Over the last five years, the 27 member ...
US HEALTH officials are reevaluating a US$590 million contract for bird flu shots that the Biden administration awarded to Moderna, sources familiar with the matter said. Read more at The Business ...
A US-educated former Goldman Sachs banker, Kirill Dmitriev has cut an unexpected figure at recent talks between the US and ...
The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...
Influenza has run rampant this winter, but numbers are leveling out, said Dr. Bisola Ojikutu of the city’s Public Health ...
A March meeting of outside advisers to the United States Food and Drug Administration to discuss the composition of flu ...